A detailed history of Kellett Schaffner Wealth Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Kellett Schaffner Wealth Advisors LLC holds 287 shares of LLY stock, worth $223,463. This represents 0.24% of its overall portfolio holdings.

Number of Shares
287
Previous 1,371 79.07%
Holding current value
$223,463
Previous $1.24 Million 79.53%
% of portfolio
0.24%
Previous 1.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$772.14 - $960.02 $836,999 - $1.04 Million
-1,084 Reduced 79.07%
287 $254,000
Q4 2023

Jan 31, 2024

BUY
$525.19 - $619.13 $36,763 - $43,339
70 Added 5.38%
1,371 $799,000
Q3 2023

Nov 06, 2023

SELL
$434.7 - $599.3 $129,105 - $177,992
-297 Reduced 18.59%
1,301 $698,000
Q2 2023

Aug 07, 2023

SELL
$350.74 - $468.98 $24,551 - $32,828
-70 Reduced 4.2%
1,598 $749,000
Q2 2022

Aug 08, 2022

BUY
$278.73 - $327.27 $464,921 - $545,886
1,668 New
1,668 $541,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Kellett Schaffner Wealth Advisors LLC Portfolio

Follow Kellett Schaffner Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kellett Schaffner Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kellett Schaffner Wealth Advisors LLC with notifications on news.